This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITATAstraZeneca Imfinzi approved in EU for muscle-invasive bladder cancer
Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger PartnerPfizer's Abrocitinib Phase III Data Accepted by CDSCO Expert Committee
COVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of wordsCOVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of words
Brain Cancer Drug Found in Wrong Packaging at Kerala RCC, SHRC Steps InGovt Panel Makes This Approval Mandatory For New Drug Licenses
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataCDSCO Panel Asks Glenmark To Justify BE Waiver for FDC Inhalation Suspension With Scientific...
CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III StudySun Pharma Gets SEC Nod to Begin Phase III Trial of Cough Drug Gefapixant
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealUSFDA grants priority review for Winrevair label update based on ZENITH Trial: Merck
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: Report
Emcure Pharma Gets CDSCO Panel Nod to Conduct Phase IV Trial on Drospirenone TabletsBain Capital divests 2.4 percent stake in Emcure Pharma for Rs 563 crore
CDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin StudyShilpa Pharma Lifesciences Unit-1 successfully completes GMP inspection from Brazilian regulatory...
Nasal SprayLupin rolls out Nasal spray for rhinorrhea relief in US
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis
X